Zhejiang Jingxin Pharmaceutical Co., Ltd. (SZSE: 002020)
Health Care · Pharmaceuticals · CN
CN¥11.83
+4.32% today · -41.7% 1Y
Zhejiang Jingxin Pharmaceutical Co., Ltd. (SZSE: 002020) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.45B and employs 3,732 people.
Over the last twelve months the share price has lost 41.7%, trading between 11.11 and 21.65.
Tweenvest scores Zhejiang Jingxin Pharmaceutical Co., Ltd. across four factors: quality 81/100, value 66/100, growth 37/100, dividend 58/100. Its strongest factor is quality.
002020 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.45B
- Revenue (TTM)
- $594.75M
- P/E
- 13.30
- EPS
- 0.89
- Dividend yield
- 2.96%
- Beta (5Y)
- -0.18
- 52-week high
- CN¥21.65
- 52-week low
- CN¥11.11
- Avg volume (3M)
- —
- Shares outstanding
- 820.88M
- Employees
- 3,732
- Next earnings
- —
About Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the full spectrum of pharmaceutical activities, from research and development to manufacturing and sales within the country. Its diverse product line includes active pharmaceutical ingredients (APIs), along with a wide array of finished medications such as antihypertensives, various antibiotics (including quinolones and cephalosporins), gastrointestinal remedies, antidiabetics, antipileptics, antihistamines, H+ pump inhibitors, H2 receptor blockers, cholesterol-lowering drugs, and antidepressants, as well as biopharmaceutical products. Additionally, the company is a provider of advanced medical display solutions, offering diagnostic, surgical, clinical, large-screen, integrated, and ultrasonic medical displays. Originally founded in 1974 as Zhejiang Jingxin Pharmaceutical Factory, the company officially rebranded to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000 and maintains its headquarters in Xinchang, China.
- ISIN
- CNE000001K73
- Founded
- 1990
- Listed since
- Jul 15, 2004
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tianjin Chase Sun Pharmaceutical Co.,LtdSZSE: 300026 | $1.46B | CN¥3.25 | +2.20% |
| Xiamen Kingdomway Group CompanySZSE: 002626 | $1.45B | CN¥16.13 | -0.37% |
| Pacira BioSciences, Inc.NasdaqGS: PCRX | $1.45B | $36.39 | +44.40% |
| Ningbo Menovo Pharmaceutical Co., Ltd.SHSE: 603538 | $1.45B | CN¥28.59 | +6.84% |
| Mayinglong Pharmaceutical Group Co., Ltd.SHSE: 600993 | $1.45B | CN¥22.52 | +1.67% |
| Guangdong Taienkang Pharmaceutical Co., Ltd.SZSE: 301263 | $1.45B | CN¥19.09 | -3.63% |
| ST Pharm Co.,Ltd.KOSDAQ: A237690 | $1.45B | ₩93,300.00 | +2.19% |
| Nippon Shinyaku Co., Ltd.TSE: 4516 | $1.43B | ¥3,368.00 | +0.03% |
Figures last refreshed Oct 4, 2026.